Reflect on the provided data and tweets to anticipate if the closing price of $amgn is going to increase or decrease at 2017-05-23. Kindly respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-05-09,-0.0,0.5,-0.2,0.1,0.1,0.3,0.2,-0.1,-0.2,-0.2,-0.1
2017-05-10,1.7,1.9,-0.5,-1.7,-1.7,1.5,1.6,1.6,1.4,1.4,1.5
2017-05-11,-0.1,0.3,-1.1,-0.3,-0.3,1.3,1.7,1.8,1.6,1.6,1.7
2017-05-12,0.2,0.2,-0.5,0.1,0.1,0.7,1.4,1.7,1.4,1.5,1.6
2017-05-15,-0.7,0.1,-0.8,-0.2,0.6,-0.1,0.8,1.0,0.8,0.8,0.9
2017-05-16,-0.1,0.3,-0.3,0.0,0.0,-0.3,0.6,0.9,0.8,0.8,0.9
2017-05-17,1.1,1.4,-0.1,-1.8,-1.8,1.2,2.1,2.5,2.6,2.6,2.6
2017-05-18,-0.4,0.5,-1.1,0.6,0.6,0.5,1.2,1.7,1.9,1.9,2.0
2017-05-19,0.7,1.3,-0.1,-0.9,-0.9,1.1,1.8,2.4,2.8,2.7,2.8
2017-05-22,0.4,1.0,-0.4,-2.2,-2.2,2.5,3.5,4.4,4.8,4.8,4.9

2017-05-09: rt AT_USER AT_USER awesome battle today!i was really impressed by both $amgn &amp; $omi increased earnings &amp;cash flows &amp; eps during¡­|rt AT_USER AT_USER awesome battle today!i was really impre
2017-05-10: reminder: uspto ipr ruling on $abbv '135 patent (covering humira q2w dosing4 ra) is due any day. $chrs $mnta $amgn $pfe $nvs|market commentary for thursday, may 11 - $cohr, $elf, $ba, $nuan, $cpn, $lg
2017-05-11: updated leverage comparison $vrx $agn $twtr $tst $jnj $snap $ko $pep $myl $mrk $brk $iep $amzn $googl $crm $ibm¡­ |commented on stocktwits: i believe they market their drug $amgn  repatha that ... |$a
2017-05-12: allergan - a positive outlook and a nice catalyst 4 months away  $amgn $pfe $rhhbf $rhhby $agn $teva|rt AT_USER patients deserve to live.  15 months not enough. room for all $juno $kite $bmy $mrk $amg
2017-05-13: elk grove, sacramento host the #amgen tour of california. read more:  $amgn|$amgn - sell signal at 160.44 on may 10, 17 by  trading robot #stockstowatch #stockmarket #trading #trade #investing| &lt; r
2017-05-14: bought $amgn on gap fill.|a dividend growth portfolio for total return investors  $dis $exr $hd $mpc $nke $sbux $unh $v $wba $acn $amgn $ba|a dividend growth portfolio for total return investors  $dis
2017-05-15: rt AT_USER patience leads to great dividend growth  $aapl $abbv $amgn $ba $bmy $cmcsa $csco $cvs $dis $hd $ho¡­|$amgn max pain is 162.50 for maturity 05/19/2017. prev close = 159.07.   |rt AT_USER bef
2017-05-16: $chrs $mnta $amgn etc¡ªuspto action¡ª&gt;bullish4 *all* companies seeking 2commercialize humira fobs for us mkt:¡­ |rt AT_USER $abbv $amgn $chrs ipr of humira 135 patent invalidated in ipr; big win fo
2017-05-17: $amgn: amgen highlights data to be presented at asco; oral presentation of new analysis on limited renal toxicity... | my thoughts on why most broke people think stock chatrooms are a 'scam' ! $fb $tw
2017-05-18: rt AT_USER 7 areas to watch from the asco abstracts  $incy $amgn $kite $juno $rhhby $lly $pfe $nvs $mrk $azn|amgen $amgn trading at 120% of 52-week low. worth a look? $bmy $lly $abbv $pfe  |#asco2017 
2017-05-19: manifest millennial snowflake malaise &amp; instant gratification materializes after $amgn tenders legitimate justification 4 $arwr past/future|rt AT_USER AT_USER yes little $nwbo presenting aside $am
2017-05-20: commented on 3 things in biotech you should learn today: may 20, 2017  $amgn $mrk $nvs $rhhbf $rhhby|$amgn max pain is 157.50 for maturity 05/26/2017. prev close = 156.51.   |$kite $juno $celg $ziop $
2017-05-21: rt AT_USER $amgn amgen¡¯s ph 3 news tonite is bad, estimates were for $800m+ or so, stock should be down $3-$5 on this|rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn'
2017-05-22: $aapl $amat $amgn $amtd $amzn $atvi trade long and short positions from the #nasdaq, up to 1500% since 2010.  $spy|$amgn enbrel good into the 2028-29 timeframe, so no such perverse incentive to keep s
Answer:
date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-05-09,-0.0,0.5,-0.2,0.1,0.1,0.3,0.2,-0.1,-0.2,-0.2,-0.1
2017-05-10,1.7,1.9,-0.5,-1.7,-1.7,1.5,1.6,1.6,1.4,1.4,1.5
2017-05-11,-0.1,0.3,-1.1,-0.3,-0.3,1.3,1.7,1.8,1.6,1.6,1.7
2017-05-12,0.2,0.2,-0.5,0.1,0.1,0.7,1.4,1.7,1.4,1.5,1.6
2017-05-15,-0.7,0.1,-0.8,-0.2,0.6,-0.1,0.8,1.0,0.8,0.8,0.9
2017-05-16,-0.1,0.3,-0.3,0.0,0.0,-0.3,0.6,0.9,0.8,0.8,0.9
2017-05-17,1.1,1.4,-0.1,-1.8,-1.8,1.2,2.1,2.5,2.6,2.6,2.6
2017-05-18,-0.4,0.5,-1.1,0.6,0.6,0.5,1.2,1.7,1.9,1.9,2.0
2017-05-19,0.7,1.3,-0.1,-0.9,-0.9,1.1,1.8,2.4,2.8,2.7,2.8
2017-05-22,0.4,1.0,-0.4,-2.2,-2.2,2.5,3.5,4.4,4.8,4.8,4.9

2017-05-09: rt AT_USER AT_USER awesome battle today!i was really impressed by both $amgn &amp; $omi increased earnings &amp;cash flows &amp; eps during¡­|rt AT_USER AT_USER awesome battle today!i was really impre
2017-05-10: reminder: uspto ipr ruling on $abbv '135 patent (covering humira q2w dosing4 ra) is due any day. $chrs $mnta $amgn $pfe $nvs|market commentary for thursday, may 11 - $cohr, $elf, $ba, $nuan, $cpn, $lg
2017-05-11: updated leverage comparison $vrx $agn $twtr $tst $jnj $snap $ko $pep $myl $mrk $brk $iep $amzn $googl $crm $ibm¡­ |commented on stocktwits: i believe they market their drug $amgn  repatha that ... |$a
2017-05-12: allergan - a positive outlook and a nice catalyst 4 months away  $amgn $pfe $rhhbf $rhhby $agn $teva|rt AT_USER patients deserve to live.  15 months not enough. room for all $juno $kite $bmy $mrk $amg
2017-05-13: elk grove, sacramento host the #amgen tour of california. read more:  $amgn|$amgn - sell signal at 160.44 on may 10, 17 by  trading robot #stockstowatch #stockmarket #trading #trade #investing| &lt; r
2017-05-14: bought $amgn on gap fill.|a dividend growth portfolio for total return investors  $dis $exr $hd $mpc $nke $sbux $unh $v $wba $acn $amgn $ba|a dividend growth portfolio for total return investors  $dis
2017-05-15: rt AT_USER patience leads to great dividend growth  $aapl $abbv $amgn $ba $bmy $cmcsa $csco $cvs $dis $hd $ho¡­|$amgn max pain is 162.50 for maturity 05/19/2017. prev close = 159.07.   |rt AT_USER bef
2017-05-16: $chrs $mnta $amgn etc¡ªuspto action¡ª&gt;bullish4 *all* companies seeking 2commercialize humira fobs for us mkt:¡­ |rt AT_USER $abbv $amgn $chrs ipr of humira 135 patent invalidated in ipr; big win fo
2017-05-17: $amgn: amgen highlights data to be presented at asco; oral presentation of new analysis on limited renal toxicity... | my thoughts on why most broke people think stock chatrooms are a 'scam' ! $fb $tw
2017-05-18: rt AT_USER 7 areas to watch from the asco abstracts  $incy $amgn $kite $juno $rhhby $lly $pfe $nvs $mrk $azn|amgen $amgn trading at 120% of 52-week low. worth a look? $bmy $lly $abbv $pfe  |#asco2017 
2017-05-19: manifest millennial snowflake malaise &amp; instant gratification materializes after $amgn tenders legitimate justification 4 $arwr past/future|rt AT_USER AT_USER yes little $nwbo presenting aside $am
2017-05-20: commented on 3 things in biotech you should learn today: may 20, 2017  $amgn $mrk $nvs $rhhbf $rhhby|$amgn max pain is 157.50 for maturity 05/26/2017. prev close = 156.51.   |$kite $juno $celg $ziop $
2017-05-21: rt AT_USER $amgn amgen¡¯s ph 3 news tonite is bad, estimates were for $800m+ or so, stock should be down $3-$5 on this|rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn'
2017-05-22: $aapl $amat $amgn $amtd $amzn $atvi trade long and short positions from the #nasdaq, up to 1500% since 2010.  $spy|$amgn enbrel good into the 2028-29 timeframe, so no such perverse incentive to keep s